For decades, scientists thought mitochondria did one thing: make energy (ATP).
They were the “powerhouse of the cell” and that was the end of the story.
Then in 2015, a research team led by Changhan Lee at USC discovered something unexpected hiding in mitochondrial DNA: a signaling peptide called MOTS-c.
It wasn’t supposed to be there.
Mitochondrial DNA was thought to only encode proteins for the electron transport chain.
Finding an active signaling molecule in there rewrote a fundamental assumption about cell biology.
What MOTS-c does:
MOTS-c is a 16-amino acid peptide that acts as a metabolic regulator.
In preclinical studies, it’s shown effects on several pathways that matter for aging and performance:
Metabolic regulation: MOTS-c activates AMPK — the same pathway targeted by metformin and exercise. This improves glucose uptake, fatty acid oxidation, and metabolic flexibility.
Exercise mimetic effects: In mouse models, MOTS-c administration improved exercise capacity and endurance, even in older animals.
Aging: MOTS-c levels decline with age. Studies suggest this decline correlates with increased insulin resistance, decreased mitochondrial function, and higher inflammatory markers.
Stress response: MOTS-c can translocate to the nucleus during cellular stress and directly regulate gene expression — essentially acting as a communication signal from mitochondria to the genome.
Why this matters for the biohacking world:
MOTS-c sits at the intersection of longevity, metabolic health, and physical performance.
It’s being researched as a potential intervention for age-related metabolic decline, obesity, and exercise intolerance.
Some researchers have called it “exercise in a peptide” — which is an overstatement, but it gives you a sense of the mechanistic profile.
It’s still early. Most data is preclinical. But MOTS-c represents a new category of peptide research — mitochondrial-derived peptides (MDPs) — that barely existed a decade ago and is now one of the fastest-growing areas in longevity science.
Common research protocols use 5–10mg MOTS-c subcutaneously, 3–5 times per week.
Some researchers stack it alongside exercise protocols to study potential synergistic effects on metabolic markers.
Tomorrow I’m going to shift gears and talk about something practical: how to actually structure a peptide protocol so it’s organized, trackable, and doesn’t turn into chaos.